Skip to main content
WeightCited

DHEA के लिए Abdominal Fat Reduction

C साक्ष्य की तुलना करें छोटे अध्ययनों से सीमित साक्ष्य उपलब्ध हैं, लेकिन कुछ सकारात्मक संकेत मौजूद हैं।

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Ddhea\u0026condition\u003Dabdominal\u002Dfat'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

Key Study Findings

Other n=60 7 weeks
Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing …
Dose: 200 mg/kg for 45 days बनाम: DHEA-induced PCOS model controls Outcome: PCOS attenuation via TLR4/MyD88/NF-kB pathway प्रभाव: BW p=0.025, testosterone p=0.005 <0.05 multiple endpoints

जनसंख्या: DHEA-induced PCOS C57BL/6J mice (4 groups, n=15)

In Vitro 3.0 weeks
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Dose: 4 g बनाम: Control Outcome: Gut microbiota composition प्रभाव: None None

जनसंख्या: None

Key Statistics

5

अध्ययन

200

प्रतिभागी

Positive

C

ग्रेड

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
25-50 mg/day DHEA
guidance:
Guided by serum DHEA-S levels
7ketodhea:
100 mg 2x/day

अधिकतम सीमा: 50 mg/day for general use; higher doses under medical supervision only

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
200 mg/kg for 45 days 7 weeks Positive 60
4 g 3.0 weeks Positive --

सेवन का सर्वोत्तम समय: Morning (mimics natural diurnal pattern)

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Acne
  • Hair loss
  • Facial hair growth (women)
  • Mood changes
  • Hormonal side effects

ज्ञात अंतःक्रियाएँ

  • Hormone-sensitive cancers (avoid)
  • Antiestrogens (may counteract)
  • Insulin and diabetes medications
  • WADA-banned in competitive sports

सहनीय अधिकतम सेवन: 50 mg/day for general use; higher doses under medical supervision only

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does DHEA help with Abdominal Fat Reduction?
Based on 5 studies with 200 participants, there is limited but promising evidence that DHEA may support Abdominal Fat Reduction management. Our evidence grade is C (Some Evidence).
How much DHEA should I take for Abdominal Fat Reduction?
Studies have used various dosages. A commonly studied range is 25-50 mg/day DHEA. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of DHEA?
Reported side effects may include Acne, Hair loss, Facial hair growth (women), Mood changes. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for DHEA and Abdominal Fat Reduction?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री Abdominal Fat Reduction

References

  1. [1] Qin Yang et al.. Sci Rep. 2024. Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. doi:10.1038/s41598-024-81034-5 PubMed
  2. [2] Jing Xue et al.. Endocr J. 2019. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. doi:10.1507/endocrj.EJ18-0567 PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।